6) Protein smoothies
Carmot is currently conducting a multi-center, randomized, placebo-controlled Phase 2 clinical trial of CT-868 in participants with overweight/obesity and T1D to assess efficacy, safety, tolerability, and pharmacokinetics
Surgery is typically a last resort, especially with so many regenerative and non-invasive alternatives available today
And the what's interesting, the studies are sometimes using 600 milligrams, but it seems to see be, the sweet dose is like 1200 to 1800 milligrams a day
It is not intended for human, veterinary, therapeutic, cosmetic or personal use
There are some studies which show promise, but its not a quick fix. Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more